Round 1 Winners!
Proof of Usefulness Report

Bainom

Analysis completed on 3/21/2026

-6.65
Proof of Usefulness Score
Lab Mode

The project description outlines a high-concept bioinformatics platform, but the submission is heavily penalized due to severe red flags and unsupported claims. Asserting that 'most people have used my product' and targeting 'everyone' is absurd for an early-stage, specialized biotech AI platform. These highly unrealistic claims reflect poor response quality and zero verifiable traction, pushing the final score below zero as per the calibration guidelines for projects with clear red flags.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+2.5
Audience Reach Impact-4.0
Technical Innovation+1.5
Evidence Of Traction-7.5
Market Timing Relevance+1.0
Functional Completeness-0.5
Subtotal-7
Usefulness Multiplierx0.95
Final Score-7

Project Details

Project URL
Description
Bainom is an early-stage biotech developing the next generation of artificial intelligence (AI) and machine learning (ML) driven bioinformatics platform - The BAINOM-nX, explicitly focused on making actionable multi-omic data and its inference accessible to all. Our systems biology-oriented platform, based on the inter-disciplinary expertise of the core team, creates a one-stop, multi-omic bioinformatics ecosystem with critical applications in drug discovery, precision health, and biomedical research. We achieve this by combining the largest collection of cloud-based AI/ML bioinformatic workflows, unique multi-omic data silos of clinically actionable features, deep mining of all available -omics dataspace, and dynamic, multi-layered visualization of inferred patterns. In parallel, by exploiting our powerful platform and interdisciplinary computational/experimental biology experience, we identify and validate hitherto unknown biomarkers and druggable targets for difficult-to-treat and rare diseases. Our mission is to transform therapeutics of difficult-to-treat diseases and accelerate discovery of new treatments through AI/ML driven solutions that unleash the full clinical potential of multi-omic data.

Algorithm Insights

Market Position
Early stage requiring focused development
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline